JMI LABS IS NOW PART OF LEARN MORE

In vitro activity of gemifloxacin (GEMI) against 11,311 clinical bacterial isolates collected from the Latin American region, Lead author: Gales AC, presented at 42nd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2002, San Diego, California

View publication